Last updated: 4 February 2021 at 4:28pm EST

Barbara White Net Worth




The estimated Net Worth of Barbara White is at least $12.5 Million dollars as of 17 March 2020. Barbara White owns over 15,606 units of Corbus Pharmaceuticals Inc stock worth over $10,869,698 and over the last 10 years he sold CRBP stock worth over $0. In addition, he makes $1,672,000 as Chief Medical Officer  at Corbus Pharmaceuticals Inc.

Barbara White CRBP stock SEC Form 4 insiders trading

Barbara has made over 31 trades of the Corbus Pharmaceuticals Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he bought 15,606 units of CRBP stock worth $56,650 on 17 March 2020.

The largest trade he's ever made was buying 38,000 units of Corbus Pharmaceuticals Inc stock on 17 August 2016 worth over $119,700. On average, Barbara trades about 6,377 units every 50 days since 2014. As of 17 March 2020 he still owns at least 206,217 units of Corbus Pharmaceuticals Inc stock.

You can see the complete history of Barbara White stock trades at the bottom of the page.





Barbara White biography

Dr. Barbara White M.D. serves as Chief Medical Officer  of the Company. Dr. White has served as our Chief Medical Officer since August 2014. Previously, Dr. White served as Senior Vice President and Head of Research and Development at Stiefel, a dermatological pharmaceutical division of GlaxoSmithKline, a public pharmaceutical company, from 2011 to 2013. From 2010 to 2011, Dr. White was Vice President and Head of Immunology Therapeutic Area at UCB, a public biopharmaceutical manufacturing company. At MedImmune, LLC, a subsidiary of AstraZeneca plc, a public pharmaceutical company, Dr. White served first as Senior Director of Clinical Development from 2006 until 2007, and then as Vice President until 2010. Prior to her pharmaceutical career, Dr. White was Professor and Associate Chair of Research, Department of Medicine, at the University of Maryland School of Medicine. She was formerly Associate Chief of Staff, Research Service, at the Baltimore Veteran Administration (VA) Medical Center, where her research focused on immune-mediated mechanisms of lung fibrosis in scleroderma. Barbara also previously served as Co-Director of the Johns Hopkins University and University of Maryland Scleroderma Center. Barbara received her medical degree from the University of Pennsylvania School of Medicine and is board certified in internal medicine, rheumatology and allergy/clinical immunology. She completed her postdoctoral studies in basic cellular immunology at the National Institutes of Health.

What is the salary of Barbara White?

As the Chief Medical Officer  of Corbus Pharmaceuticals Inc, the total compensation of Barbara White at Corbus Pharmaceuticals Inc is $1,672,000. There are 1 executives at Corbus Pharmaceuticals Inc getting paid more, with Yuval Cohen having the highest compensation of $4,001,510.



How old is Barbara White?

Barbara White is 69, he's been the Chief Medical Officer  of Corbus Pharmaceuticals Inc since 2014. There are 2 older and 9 younger executives at Corbus Pharmaceuticals Inc. The oldest executive at Corbus Pharmaceuticals Holdings Inc is Avery Catlin, 72, who is the Independent Director.

What's Barbara White's mailing address?

Barbara's mailing address filed with the SEC is C/O CORBUS PHARMACEUTICALS HOLDINGS, INC, 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062.

Insiders trading at Corbus Pharmaceuticals Inc

Over the last 10 years, insiders at Corbus Pharmaceuticals Inc have traded over $3,643,182 worth of Corbus Pharmaceuticals Inc stock and bought 2,676,074 units worth $50,292,165 . The most active insiders traders include Asset Management, Lp Chen B..., Asset Management, Lp Cormor..., and Sean F. Moran. On average, Corbus Pharmaceuticals Inc executives and independent directors trade stock every 21 days with the average trade being worth of $1,059,576. The most recent stock trade was executed by Sean F. Moran on 14 June 2024, trading 18,043 units of CRBP stock currently worth $233,837.



What does Corbus Pharmaceuticals Inc do?

corbus pharmaceuticals holdings, inc. (nasdaq: crbp) is a clinical stage drug development company targeting rare, chronic, and serious inflammatory and fibrotic diseases with clear unmet needs. the company's lead product candidate, resunab™, is a first-in-class, oral anti-inflammatory drug that acts to resolve inflammation through an endogenous pathway. resunab is scheduled to commence three phase 2 clinical trials in 2015 for the treatment of cystic fibrosis, diffuse systemic sclerosis ("scleroderma") and dermatomyositis, three diseases in which inflammation contributes to disease progression. resunab also has the potential to treat additional rare, inflammatory diseases.



What does Corbus Pharmaceuticals Inc's logo look like?

Corbus Pharmaceuticals Holdings Inc logo

Complete history of Barbara White stock trades at Corbus Pharmaceuticals Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
17 Mar 2020 Barbara White
Chief Medical Officer
Buy 15,606 $3.63 $56,650
17 Mar 2020
206,217
12 Nov 2019 Barbara White
Chief Medical Officer
Buy 3,424 $4.38 $14,997
12 Nov 2019
190,611
12 Aug 2019 Barbara White
Chief Medical Officer
Buy 1,639 $6.10 $9,998
12 Aug 2019
187,187
17 May 2019 Barbara White
Chief Medical Officer
Buy 1,389 $7.20 $10,001
17 May 2019
185,548
14 Mar 2019 Barbara White
Chief Medical Officer
Buy 4,638 $6.47 $30,008
14 Mar 2019
184,159
15 May 2018 Barbara White
Chief Medical Officer
Buy 2,586 $5.87 $15,180
15 May 2018
179,521
14 Mar 2018 Barbara White
Chief Medical Officer
Buy 2,885 $6.89 $19,878
14 Mar 2018
176,935
10 Nov 2017 Barbara White
Chief Medical Officer
Buy 2,836 $7.00 $19,852
10 Nov 2017
174,050
11 Aug 2017 Barbara White
Chief Medical Officer
Buy 2,479 $6.05 $14,998
11 Aug 2017
171,214
11 May 2017 Barbara White
Chief Medical Officer
Buy 2,435 $6.12 $14,902
11 May 2017
168,735
17 Mar 2017 Barbara White
Chief Medical Officer
Buy 4,233 $9.49 $40,171
17 Mar 2017
166,300
22 Nov 2016 Barbara White
Chief Medical Officer
Buy 1,000 $7.75 $7,750
22 Nov 2016
162,067
17 Aug 2016 Barbara White
Chief Medical Officer
Buy 38,000 $3.15 $119,700
17 Aug 2016
161,067
17 Aug 2016 Barbara White
Chief Medical Officer
Buy 38,000 $3.15 $119,700
17 Aug 2016
161,067
8 Jun 2016 Barbara White
Chief Medical Officer
Buy 1,935 $3.10 $5,999
8 Jun 2016
123,067
8 Jun 2016 Barbara White
Chief Medical Officer
Buy 1,935 $3.10 $5,999
8 Jun 2016
123,067
1 Jun 2016 Barbara White
Chief Medical Officer
Buy 2,570 $3.52 $9,046
1 Jun 2016
121,132
1 Jun 2016 Barbara White
Chief Medical Officer
Buy 2,570 $3.52 $9,046
1 Jun 2016
121,132
19 Nov 2015 Barbara White
Chief Medical Officer
Buy 4,000 $1.67 $6,680
19 Nov 2015
118,562
19 Nov 2015 Barbara White
Chief Medical Officer
Buy 700 $1.68 $1,176
19 Nov 2015
114,562
3 Sep 2015 Barbara White
Chief Medical Officer
Buy 10,000 $1.84 $18,400
3 Sep 2015
113,862
25 Aug 2015 Barbara White
Chief Medical Officer
Buy 6,000 $1.87 $11,220
25 Aug 2015
103,862
21 Aug 2015 Barbara White
Chief Medical Officer
Buy 10,000 $2.05 $20,500
21 Aug 2015
97,862
18 Aug 2015 Barbara White
Chief Medical Officer
Buy 20,000 $1.90 $38,000
18 Aug 2015
87,862
15 Jun 2015 Barbara White
Chief Medical Officer
Buy 2,250 $3.25 $7,313
15 Jun 2015
67,862
12 Jun 2015 Barbara White
Chief Medical Officer
Buy 6,000 $3.00 $18,000
12 Jun 2015
65,612
4 Dec 2014 Barbara White
Chief Medical Officer
Buy 3,300 $3.00 $9,900
4 Dec 2014
59,612
1 Dec 2014 Barbara White
Chief Medical Officer
Buy 16,448 $3.00 $49,344
1 Dec 2014
56,312
28 Nov 2014 Barbara White
Chief Medical Officer
Buy 19,933 $3.00 $59,799
28 Nov 2014
39,864
26 Nov 2014 Barbara White
Chief Medical Officer
Buy 13,400 $3.00 $40,200
26 Nov 2014
19,931
25 Nov 2014 Barbara White
Chief Medical Officer
Buy 6,531 $3.03 $19,789
25 Nov 2014
6,531


Corbus Pharmaceuticals Inc executives and stock owners

Corbus Pharmaceuticals Inc executives and other stock owners filed with the SEC include: